[
  {
    "ts": null,
    "headline": "Seeking a Cure for Sickly Corporate Governance at SinoVac",
    "summary": "Chinese SinoVac Biotech Ltd. (Nasdaq: SVA) shares have been frozen since 2019 amid shareholder disputes when market cap was about $500 million SinoVac developed a wildly successful Covid vaccine and has over $10 billion in cash on balance sheet but investors have had no dividends or liquidity Current board is fending off a competing slate […] The post Seeking a Cure for Sickly Corporate Governance at SinoVac appeared first on CorpGov.",
    "url": "https://finnhub.io/api/news?id=0b20b5bf08f5af1f0f3aeedf2af0958eb065f7fa41a3ba3d7fe21218b6750636",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1750873283,
      "headline": "Seeking a Cure for Sickly Corporate Governance at SinoVac",
      "id": 135532247,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRNA",
      "source": "Yahoo",
      "summary": "Chinese SinoVac Biotech Ltd. (Nasdaq: SVA) shares have been frozen since 2019 amid shareholder disputes when market cap was about $500 million SinoVac developed a wildly successful Covid vaccine and has over $10 billion in cash on balance sheet but investors have had no dividends or liquidity Current board is fending off a competing slate […] The post Seeking a Cure for Sickly Corporate Governance at SinoVac appeared first on CorpGov.",
      "url": "https://finnhub.io/api/news?id=0b20b5bf08f5af1f0f3aeedf2af0958eb065f7fa41a3ba3d7fe21218b6750636"
    }
  },
  {
    "ts": null,
    "headline": "Moderna (MRNA): Buy, Sell, or Hold Post Q1 Earnings?",
    "summary": "Moderna’s stock price has taken a beating over the past six months, shedding 33.6% of its value and falling to $26.85 per share. This was partly due to its softer quarterly results and may have investors wondering how to approach the situation.",
    "url": "https://finnhub.io/api/news?id=85d28f562a4f812562df522e842d7c6113eef59680d508c3f239eb35c9f66f6d",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1750824177,
      "headline": "Moderna (MRNA): Buy, Sell, or Hold Post Q1 Earnings?",
      "id": 135526324,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRNA",
      "source": "Yahoo",
      "summary": "Moderna’s stock price has taken a beating over the past six months, shedding 33.6% of its value and falling to $26.85 per share. This was partly due to its softer quarterly results and may have investors wondering how to approach the situation.",
      "url": "https://finnhub.io/api/news?id=85d28f562a4f812562df522e842d7c6113eef59680d508c3f239eb35c9f66f6d"
    }
  }
]